New Lantern is a technology company.
New Lantern is an AI-driven platform designed to enhance radiology workflows by automating measurements and streamlining disease evolution analysis.
New Lantern has raised $19.0M across 1 funding round.
New Lantern has raised $19.0M in total across 1 funding round.
New Lantern has raised $19.0M in total across 1 funding round.
New Lantern's investors include Alt Capital, Andreessen Horowitz, Benchmark, Craft Ventures, Flex Capital, Floodgate, Founder Collective, Greylock, LGF, Lobby Capital, Scott Sandell, Next Level Ventures.
New Lantern is a San Francisco-based technology company founded in 2021 that builds an AI-powered, cloud-native radiology platform called Curie, serving radiologists and healthcare providers.[1][2][4][5] It integrates PACS (Picture Archiving and Communication System) viewing, AI-assisted reporting, intelligent workflow management, and specialized tools like automated measurements, report generation, and case distribution to solve inefficiencies in radiology diagnostics, such as clunky software switching, slow image loading, and tedious tasks like 3D measurements.[1][2][3][4] With $19 million in Series A funding led by Benchmark, the platform supports modalities including mammography and PET/CT, delivering sub-second load times and boosting efficiency amid radiologist shortages—trusted by practices like Radiology Associates, LLP.[1][2][4][5]
New Lantern was founded in 2021 by CEO Shiva Suri, an engineer previously at Confluent, inspired by his mother's frustrations as a radiologist dealing with outdated PACS and reporting software that required constant switching and slowed workflows.[2][4] The idea emerged from observing her daily tedium—managing medical image libraries and translating scans into diagnoses—prompting Suri to build a unified, AI-native platform to modernize radiology, akin to the shift from film to PACS 25 years ago.[2][4] Early traction includes adoption by radiology practices, validation from his mother, and a $19M Series A in November 2024 led by Benchmark, with backers like Afore Capital, SV Angel, and angels including Guillermo Rauch and Gokul Rajaram.[1][2][4]
New Lantern rides the AI augmentation wave in healthcare imaging, addressing radiologist shortages and outdated PACS systems rather than replacing humans—unlike early AI hype focused on full image analysis, which investors like Benchmark's Eric Vishria deem unready.[2] Timing aligns with rising breast cancer screening, specialized imaging bottlenecks, and cloud migration needs, positioning it to disrupt a market stagnant since PACS invention.[2][4] It influences the ecosystem by enabling faster diagnostics, higher productivity, and better patient care, with early practice adoption signaling momentum in value-based care and AI copilots for clinicians.[1][2][3][5]
New Lantern is poised to redefine radiology as the first complete AI suite, expanding modalities and scaling with Benchmark's backing amid clinician shortages and AI maturity.[2][4] Trends like AI workflow automation, cloud-native health tech, and regulatory tailwinds for diagnostic tools will propel growth, potentially capturing share from legacy vendors.[1][2][4] Its influence may evolve into ecosystem standards for AI-radiology integration, with next steps including broader customer rollout and advanced features—transforming "busywork" into the efficiency edge that started with one radiologist's pain point.[2][5]
New Lantern has raised $19.0M across 1 funding round. Most recently, it raised $19.0M Series A in November 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2024 | $19.0M Series A | Alt Capital, Andreessen Horowitz, Benchmark, Craft Ventures, Flex Capital, Floodgate, Founder Collective, Greylock, LGF, Lobby Capital, Scott Sandell, Next Level Ventures, Robot Ventures, Saga, Sequoia Capital, SmartStart Fund, SNR, Tiger Global Management, Aston Motes, DJ Patil, Greg Brockman, Guillermo Rauch, Harry Hurst, Jim Pitkow, Leore Avidar, Matt Mazzeo, Oleg Rogynskyy, Sam Altman, Scott Belsky, Stacy Brown-Philpot |